All Online

73 - 84 of 84 results

Refine

Active filters

Infectious Diseases
0.5 CME CREDIT

In the eleventh episode of Pri-Med’s weekly web series on COVID-19, faculty will discuss recent publications and issues related to COVID-19 including the retraction of two major trials on hydroxychloroquine from Lancet and NEJM, the results of a trial investigating hydroxychloroquine as post-exposure prophylaxis for COVID-19, and the results of a study investigating transmission and viral shedding of COVID-19. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 6/10/2020 and they are subject to change as new information is published.


0.5 CME CREDIT

In the twelfth episode of Pri-Med’s weekly web series on COVID-19, faculty will discuss the most recent information on COVID-19 vaccines and testing. This episode will review the mechanisms and clinical trial status of each vaccine currently in development and discuss recent literature comparing different sampling techniques in COVID-19 testing. Lastly, faculty will explore how pre-test probability is important to understanding test accuracy. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 6/16/2020 and they are subject to change as new information is published.


1 CME CREDIT

In the eighth episode of Pri-Med’s weekly web series on COVID-19, faculty will continue their discussion on treatment by describing immunomodulatory therapies and additional antivirals under investigation for COVID-19. They will also review the various types of vaccines currently in development for COVID-19. Specific therapies to be discussed in this episode will include: • Antivirals: baloxavir marboxil, favipiravir, nitazoxanide, oseltamivir, ribavirin, umifenovir • Glucocorticoids • Anakinra • Tocilizumab • Interferon beta-1b • Vaccine mRNA-1273 Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 05/21/2020 and they are subject to change as new information is published.


0.5 CME CREDIT

COVID-19 Panel Discussion

0.50 CME
0.50 AANP

Join an expert panel hosted by Pamela Kushner, MD with infectious disease experts Paul Sax, MD and Daniel Solomon, MD as they answer your COVID-19 questions. In addition to answering live questions from the audience, faculty will share their clinical experiences, and discuss the most relevant updates in the literature and current recommendations regarding COVID-19. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 06/26/2020 and they are subject to change as new information is published.


0.3 CME CREDIT

Adults between the ages of 18 through 64 with immunocompromising conditions due to either anatomic defects or impaired immune response are at the highest risk for invasive pneumococcal disease. They need two different pneumococcal vaccines: pneumococcal conjugate vaccine (PCV13) at the time the risk factor is recognized and pneumococcal polysaccharide vaccine (PPSV23) at least 8 weeks later. This podcast will discuss how to identify these patients at high risk for pneumococcal disease and implement guidelines for administration of pneumococcal vaccination in this population. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 6/18/2020 and they are subject to change as new information is published.


0.3 CME CREDIT

The Advisory Committee on Immunization Practices (ACIP) makes shared clinical decision-making recommendations when individuals may benefit from vaccination, but broad vaccination of all people in that group is unlikely to have population-level impact. Such a recommendation is applicable to pneumococcal vaccines whereby pneumococcal conjugate vaccine (PCV13) is recommended for all adults 65 and older, while the administration of pneumococcal conjugate vaccine (PCV13) is based on shared decision-making. In this podcast, we will discuss the ACIP recommendations and the use of shared decision-making as it applies to pneumococcal vaccines. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 6/18/2020 and they are subject to change as new information is published.


0.35 CME CREDIT

Join infectious disease specialist, Dr. Daniel Solomon, in the last episode of a 3-part podcast series, as he discusses important concepts related to influenza that are especially relevant in 2020 during the COVID pandemic. During this episode, he will answer frequently asked questions that are compiled from previous Pri-Med activities on the topic of influenza. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 10/13/2020 and they are subject to change as new information is published.


1.5 CME CREDITS

This session will explore some of the most relevant questions clinicians have as we approach a year into the COVID-19 pandemic. Faculty will review the cardiovascular complications that are directly and indirectly attributed to COVID-19 that have been documented since the onset of the pandemic as sequelae of fear leading to avoidance of prescription medication use, emergency department avoidance, and missed routine healthcare. This session will explore “long” COVID-19 and long-term cardiovascular manifestations and population-level health implications. Faculty will compare COVID-19 to influenza and explore how to distinguish presentation of these viruses. Lastly, we will focus on preventative measures including the development of a COVID-19 vaccine. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 11/13/2020, and they are subject to change as new information is published.


0.5 CME CREDIT

In the fifteenth episode of Pri-Med’s weekly web series on COVID-19, faculty will revisit the data on chloroquine and hydroxychloroquine in the treatment of COVID-19 and will discuss the data on the effectiveness of hydroxychloroquine in post-exposure prophylaxis. Faculty will also review the recent data on proton pump inhibitors (PPI) and histamine2-receptor antagonists (H2RA) as they relate to COVID-19 risk, giving you the most current information on how to manage your patients taking these medications.


1 CME CREDIT

Take part in this interactive video-based activity that has been engineered to support your learning! Join faculty as they discuss influenza diagnosis, testing, and management through a combination of video, quiz-questions, pop-up teaching points, and downloadable resources. Take a deep dive into guideline recommendations for influenza testing and treatment (including prophylactic treatment) and review the indications, safety, and efficacy of currently available antiviral medications. Through this activity, you will have access to a robust resource library, including slides, abstracts, and practice tools selected by the faculty, and which can be downloaded for future reference. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 05/08/2020 and they are subject to change as new information is published.


0.5 CME CREDIT

In the nineteenth episode of Pri-Med’s web series on COVID-19, faculty will explore recent reports of subclinical myocarditis among those that have recovered from COVID-19. Faculty will also discuss how, as we move into flu season, we can understand the differences in COVID-19 and influenza when it comes to symptoms and outcomes in both the adult and pediatric populations.


0.5 CME CREDIT

Flu season is here. Do you have any burning questions about influenza management? Get your questions answered during this live 30-minute Q&A session, hosted by primary care specialist, Pamela Kushner MD, and infectious disease specialist, Daniel Solomon MD. The duo will start the session with a brief patient case and answers to common questions they receive, followed by an open question and answer period.